Restart Life Sciences reports 34% revenue growth in April 2026 after Holy Crap Foods acquisition.

Restart Life Sciences achieved a 34.2% revenue increase in April 2026 compared to April 2025, reaching $106,288 following its acquisition of Holy Crap Foods in February 2026. The growth was driven by strong wholesale performance across over 800 Canadian retail locations and a significant boost in e-commerce sales, especially on Amazon, where revenue rose 145.7% from April 2024. The company continues to focus on optimizing distribution channels and expanding its presence in Canada, with plans to enter the U.S. and other international markets. Management views this milestone as validation of their strategy centered on gut health and functional nutrition.